e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Paediatric epidemiology: wheeze, asthma and other respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increasing prevalence of complicated pneumonia and pneumococcal related hemolytic uremic syndrome despite territory-wide program of pneumococcal conjugated vaccination (PCV-7) program in children
G. Wong, T. Nelson, G. Chiang, T. F. Leung, P. Chan, M. Ip (Shatin, Sahtin, Hong Kong)
Source:
International Congress 2014 – Paediatric epidemiology: wheeze, asthma and other respiratory diseases
Session:
Paediatric epidemiology: wheeze, asthma and other respiratory diseases
Session type:
Thematic Poster Session
Number:
4251
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Wong, T. Nelson, G. Chiang, T. F. Leung, P. Chan, M. Ip (Shatin, Sahtin, Hong Kong). Increasing prevalence of complicated pneumonia and pneumococcal related hemolytic uremic syndrome despite territory-wide program of pneumococcal conjugated vaccination (PCV-7) program in children. Eur Respir J 2014; 44: Suppl. 58, 4251
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013
Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Do school holidays affect adult pneumococcal community acquired pneumonia incidence?
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
The remaining challenges of pneumococcal disease in adults
Source: Eur Respir Rev 2012; 21: 57-65
Year: 2012
LATE-BREAKING ABSTRACT: Pneumococcal serotypes causing community-acquired pneumonia (CAP) among hospitalized adults in Spain using a new urinary antigen detection (UAD) test. The CAPA study
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Impact of pneumococcal vaccination in children in the distribution of serotypes in bacteriemic pneumococcal pneumonia in adults
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Incidence of hospitalized all-cause pneumonia, and serotype distribution of hospitalized
streptococcus pneumoniae
pneumonia in Norway 2008-2009
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013)
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Aetiology of paediatric pneumonia after the introduction of pneumococcal conjugate vaccine
Source: Eur Respir J 2013; 42: 1595-1603
Year: 2013
Impact of the vaccination campaign on pneumococcal pneumonia after the great East Japan earthquake
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
The burden of hospitalized all-cause and pneumococcal pneumonia in Spain (2010)
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Pneumococcal and influenza vaccine uptake in patients discharged from an acute medical hospital
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
No preventive effects of 23-valent pneumococcal polysaccharide vaccine in patients with chronic renal failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Complicated pneumococcal pneumonia in adults
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Effects of vaccination on clinical presentation of community acquired pneumonia (CAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Pneumococcal serotypes in adult lower respiratory tract infections in primary care in Belgium
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
The burden of multi-cause and pneumococcal pneumonia hospitalisations in the RhÔne-Alpes region, France (2005–2010)
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013
Severe complicated pneumococcal pneumonia in young adults
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013
Clinical peculiarities of mycoplasma infection in children with community pneumonia
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept